The Most Misused Word in Skincare
Americans spend over $50 billion on skincare annually. A significant portion of that money is spent on products labelled "cosmeceutical" — a word that sounds clinical, implies scientific validation, and suggests a higher standard than conventional cosmetics. It is also a word that has no legal definition anywhere in the United States Code.
The FDA recognises two categories of topical products: cosmetics and drugs. There is no third category. The term "cosmeceutical" was coined by Dr. Albert Kligman in the 1980s to describe a product that fell between the two — something that could affect skin function without meeting the full regulatory requirements of a drug. It was a useful concept. It has since been adopted by hundreds of brands as a marketing term, applied to products whose only connection to science is the lab coat on the model in the advertisement.
This article is not about whether cosmeceuticals exist. They do. This article is about how to tell the difference between a genuine cosmeceutical and a product that simply calls itself one.
The Regulatory Truth That Most Brands Won't Tell You
Here is the most important fact in skincare regulation: it is not the ingredient that determines whether a product is a cosmetic or a drug. It is the claim.
Consider a cream containing retinol. If the label says "reduces the appearance of wrinkles," it is regulated as a cosmetic. If the label says "reduces wrinkles," it is regulated as a drug. Identical ingredient. Identical concentration. Different claim. Different classification.
This distinction means a brand can formulate a product with the same ingredient list as a clinically validated cosmeceutical, make a cosmetic claim, and legally use the word "cosmeceutical" in its marketing — all while maintaining plausible deniability about whether the product actually does anything biologically.
The system does not require evidence for cosmeceutical claims. It requires only that the claim be phrased carefully enough to stay in the cosmetic lane. This is why credentials matter more than labels. A brand can call itself a cosmeceutical tomorrow. What it cannot do is produce 25 years of formulation history, a federal patent, FDA-registered manufacturing, Oregon Tilth certification, and clinical trial data — unless those things actually exist.
What a Genuine Cosmeceutical Requires
A real cosmeceutical is not defined by its label. It is defined by three things: what it changes in the skin, how deep it reaches, and at what concentration its ingredients are delivered.
What it changes. A conventional cosmetic alters the appearance of the skin temporarily. It hydrates the surface. It fills lines with film-forming polymers. It diffuses light with mica particles. A cosmeceutical is formulated to affect how skin cells function — to modulate melanin production at the enzymatic level, to signal fibroblasts to produce more collagen, to influence neurotransmitter release at the neuromuscular junction. The difference is not marketing. It is mechanism.
How deep it reaches. The stratum corneum — the outermost layer of the skin — consists of dead cells. A conventional cosmetic deposits ingredients on this layer. It cannot reach the living epidermis where cell division, collagen synthesis, and melanin regulation occur. A cosmeceutical must be engineered to penetrate this barrier. This requires specific molecular weights (small enough to pass through the lipid matrix), appropriate pH (calibrated to the skin's acid mantle at 4.5–5.5), and a delivery system capable of carrying active ingredients to the viable epidermis without triggering an immune response.
At what concentration. Many cosmetics list active ingredients on their labels — retinol, vitamin C, peptides — but at concentrations below the threshold required for a cellular response. This is not an accident. Formulating at sub-therapeutic concentrations allows a brand to list the ingredient on the label and make cosmetic claims while avoiding the stability challenges, production costs, and regulatory scrutiny associated with therapeutic levels. A genuine cosmeceutical formulates at concentrations where the ingredient does what it claims. This is harder. It is also the entire difference.
The pH Mechanism
The skin's acid mantle operates at pH 4.5–5.5. This slightly acidic environment maintains the integrity of the lipid barrier and supports the enzymatic activity responsible for natural desquamation. A formula that ignores pH can damage this barrier, cause irritation, or render its active ingredients ineffective.
Real cosmeceutical formulas are pH-calibrated to work with the acid mantle — enhancing ingredient penetration while protecting barrier function. This is not a matter of adding a buffer. It requires understanding how each active ingredient behaves at different pH levels, how the delivery system interacts with the skin's natural charge, and how the formula changes as it dries on the skin over time.
This is engineering. It requires a chemist, not a trend report. And it is why a genuine cosmeceutical takes years to develop, not months.
Who Built This and Why It Matters
Credentials are not decorations on a website. They are the only way to answer the question the regulatory system leaves unanswered: how do you know which brand is real?
Dr. Michelle Volynsky, Ph.D. — organic chemistry. For 25 years, she has worked in cosmetic chemistry R&D, solving the problem that defines the cosmeceutical category: how to get the right ingredient to the right depth at the right concentration in an organic-certified base. What a chemist sees when looking at a formula — molecular architecture, stability kinetics, delivery vehicle design — is invisible to a marketing team. That is not a criticism of marketers. It is an explanation of why some products are built by scientists and others are built by focus groups. Together with Dr. Vartan Libaridian, she co-founded the manufacturing laboratory in 1995.
Dr. Vartan Libaridian, R.Ph., Ph.D. — a pharmacist with 30 years in pharmaceutical and cosmetic chemistry R&D. His background is in systemic drug delivery — the same principles used in transdermal pharmaceutical patches, applied to cosmeceutical formulation. A pharmacist understands what a formulator alone may not: that the vehicle delivering the active ingredient determines efficacy as much as the ingredient itself. He was previously technical director at Neutrogena, bringing some of the most recognisable products in the industry to market.
Together, Dr. Volynsky and Dr. Libaridian have spent a combined five decades in formulation science. The products they build are not assembled from a catalogue of ingredients. They are engineered from first principles, with each component selected for its role in a system designed to function as a whole.
Development time as evidence. Le Serum took five years. S-ence took five years. These are not slow development cycles. They are the minimum time required to formulate a therapeutic concentration of a peptide like Argireline in a bioavailable delivery system, verify its stability over time, certify the organic base through Oregon Tilth, conduct clinical assessment, and file the regulatory documentation — all while maintaining ethical, cruelty-free, and allergen-conscious standards. A product that takes five months to develop may be effective. A product that takes five years to develop cannot be anything else.
The patent. United States Patent US 8,460,687 B1 was granted on June 11, 2013 to Yelena Michelle Volynsky and Vartan Libardian, assigned to the Cosmoceutical Research Center. It covers peeling compositions based on phytic acid — a natural antioxidant derived from rice bran — for skin resurfacing, treating hyperpigmentation, controlling sebum production, reducing pore size, and combating acne. A federal body reviewed this formulation and determined it was novel, non-obvious, and genuinely different from everything that existed before it. The same patent classification as Johnson & Johnson.
Forbes, 2010. In a feature titled "Deep Chemical Peels No Longer a Risky Business," Forbes reported on Dr. Volynsky and Dr. Libaridian's invention of PHA — a deep chemical peel that achieved outstanding results without the standard risks of scarring, infection, and general anesthesia associated with conventional deep peels. The article noted their invention "has eliminated the intense inflammation, swelling, and blistering associated with other deep peels" and that patients could "immediately return to work and achieve dramatic rejuvenation within a week."
Oregon Tilth + FDA registration. Oregon Tilth certification is among the strictest organic certifications in the United States. Achieving it at therapeutic active concentrations — where the formula must contain both potent active ingredients and certified-organic base components — is genuinely difficult. Most organic skincare brands use lower active concentrations because high-concentration actives are harder to certify. MD Cosmetique's manufacturing facility is also FDA-registered for both cosmetics and drug licensing, which means it meets federal standards for products classified as drugs — a higher bar than cosmetic-only manufacturing.
The Clinical Data That Cost Nothing to Skip
Nothing in cosmeceutical regulation requires a brand to conduct clinical trials. A product can be called a cosmeceutical, sold for decades, and never once be tested on human subjects in a controlled setting. This is why clinical data is the most reliable signal of a genuine operation.
MD Cosmetique conducted a clinical trial through the Philippines Dermatologist Research Foundation. The results: 40% reduction in comedones at week one, 72% at week four. 95% improvement in pustular lesions by week four. The acne regimen was evaluated using standardized dermatological protocols, not a customer satisfaction survey.
The phytic acid research is equally specific: clinically equivalent to 50% glycolic acid at 15 minutes — without the cytotoxicity that makes high-concentration glycolic a professional-only treatment. Ki-67 staining confirmed cell proliferation under phytic treatment. Tyrosinase inhibition was comparable to Kojic acid, which means meaningful potential for hyperpigmentation and melasma treatment without the irritation profile of standard brightening agents.
This investment in clinical evidence was not required. The fact that it exists is what separates a genuine cosmeceutical manufacturer from a brand that purchased the word from a marketing agency.
The Honest Section: Who Cosmeceuticals Are Not For
Cosmeceuticals are not for everyone. If your skin barrier is compromised — from over-exfoliation, aggressive treatments, or untreated inflammatory conditions — applying therapeutic-concentration actives can worsen the problem. Professional guidance is recommended before starting any cosmeceutical regimen.
Results require consistency. One full skin cell turnover cycle takes a minimum of 28 days. Visible changes in collagen density take six months. A cosmeceutical used sporadically will produce sporadic results. This is not a flaw in the product. It is a function of how human biology operates.
Layering multiple active products without understanding their interactions can cause damage. Two well-formulated products used together may conflict at the pH level, compete for the same delivery pathway, or collectively exceed the skin's tolerance threshold. A simplified routine designed around a single mechanism — used consistently — outperforms a complex routine assembled from conflicting ingredients.
These limitations are not reasons to avoid cosmeceuticals. They are reasons to approach them with the same seriousness the formulator applied to building them.
The Close
Most people will read this, nod, and buy the same product they were already planning to buy. That is fine. The beauty industry is built on that decision.
But if you are at the point where you want to understand what you are actually putting on your skin — where you care about the chemistry as much as the packaging — then the word "cosmeceutical" on a label tells you very little. What tells you something is who built it, how long it took, and what they were willing to prove before selling it.
That is what Dr. Volynsky and Dr. Libaridian built. That is why it took them five years.
Explore the formulations.
